Headline News

Healio spoke with Darin Messina, PhD, on the significance and practical impact of the FDA’s most recent approval of Botox Cosmetic for platysma bands.

INDIANAPOLIS — A single in-office treatment of ABBV-RGX-314 was well-tolerated and improved severity of diabetic retinopathy, according to 1-year study results presented at Academy 2024.

INDIANAPOLIS — Effective implementation of AI in optometric practice provides another tool to improve the delivery of care, according to an expert at the Academy 2024 plenary session.

Patients with autoimmune or inflammatory rheumatic diseases living in rural areas demonstrate a 24% higher mortality risk after SARS-CoV-2 infection vs. those in urban areas, according to data published in Arthritis Care & Research.

PHILADELPHIA — A “high prevalence” of extremity repetitive use injury symptoms were reported among endoscopists, which negatively affected performance, according to a presenter at the ACG Annual Scientific Meeting.

According to published results, glucagon-like peptide-1 agonists may not be associated with increased complications for patients with diabetes who undergo total hip arthroplasty.

BOSTON — Patients with chronic inducible urticaria saw improvements in itch and wheals with barzolvolimab in 12 weeks, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Sundaram Natarajan, MD, shares his experience with wide-angle viewing systems.

A 50-year-old man has been a patient in the practice for the past 25 years.

Sotagliflozin was not recommended for approval by the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee for glucose control as an adjunct to insulin in adults with type 1 diabetes and chronic kidney disease..